Revenue

With a novel 'gastric bypass in a pill' and a new CFO known for orchestrating lucrative exits, Syntis Bio is gearing up for a high-stakes battle in the booming obesity drug market.

A Maryland firm just got funding for 'universal' stem cells. This isn't just science; it's the blueprint for off-the-shelf cures and a new era of medicine.

As Acorn Energy faces investors, a recent dip in hardware revenue highlights its ongoing focus on high-margin services and advanced IoT, expanding its capacity to secure the grid.

Boxabl, known for its earthly foldable homes, eyes the Moon with a new habitat concept. Is this a real pivot or a savvy move tied to its imminent SPAC merger?

Beyond flights and hotels lies the real challenge of travel: participation. A new logistics model is ensuring that no one gets left on the sidelines.

We map digital grids and autonomous routes, but what about the biological networks that define half of humanity? An Indian brand is using ancient wisdom to build new infrastructure for women's health.

A new study reveals a 360% surge in senior fraud losses since 2021, with AI-powered scams creating a complex new threat. How can we protect our most vulnerable?

The real estate marketplace iFinder enters San Antonio, betting its vetted-investor model can out-execute traditional cash buyers in a cooling market.

Exavalu's new ExAite platform uses 'agentic AI' to automate software testing, promising huge cost savings and faster releases for the insurance sector.

A new firm, LinkConnect Innovations, has acquired 1,000+ Nokia patents. Backed by global financiers, it promises a 'reasonable' approach to licensing.

Consumers demand eco-friendly cleaners but fear they don't work. A new brand, backed by a 74-year legacy, claims its enzyme-based science can finally deliver.

A geo-targeting firm captured data from 1M cannabis consumers' phones to create a compliant ad audience. It's a strategic masterstroke, but it opens a new front in the battle over data privacy.

A Truist subsidiary just broke into an elite financial club that hasn't had a new member in two decades. Here’s why this changes the game for investors.

Synchrony's dual #1 workplace awards aren't just accolades; they're a case study in blending trust, tech, and strategic presence. Here's the real story.

One PR agency's new certification as a woman-owned business reveals a powerful economic ecosystem designed to foster inclusive growth and corporate responsibility.

With a new $24M Series A, Infinity Constellation isn't just bolting on AI—it's building an army of AI-native firms to dismantle the $6T services industry.

As corporate giants swallow local clinics, one alliance offers a lifeline. Here’s how AllyGPO and BioCareSD use AI and service to help doctors stay independent.

EVERSANA poaches Takeda's Jen Norton to lead a new tech-first unit, signaling a high-stakes bid to dominate the complex life sciences access market.

A new report reveals AI-related incidents in software development are surging, exposing a critical 'governance gap' that puts security and compliance at risk.

The iconic Eclipse name returns as an EV, but its success hinges on a strategic alliance with Nissan. Can Mitsubishi turn shared parts into a market-shattering win?